3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Sarcoma
1
Plasma cell
1
Lymphoid
1
Genitourinary
1
Classical hematology
1
Conditions
Venous Thrombosis
1
Venous Thromboembolism
1
Thrombosis
1
Pulmonary Embolism
1
Neoplasms
1
Interventions
Cyclophosphamide
37
fludarabine phosphate
35
Mycophenolic Acid
33
Whole-Body Irradiation
32
Busulfan
24
Tacrolimus
22
fludarabine
21
Peripheral Blood Stem Cell Transplantation
20
Cyclosporine
20
Melphalan
17
Antilymphocyte Serum
13
Methotrexate
12
Filgrastim
12
Granulocyte Colony-Stimulating Factor
11
Cytarabine
11
Cord Blood Stem Cell Transplantation
11
Thiotepa
9
thymoglobulin
8
eltrombopag
8
Lenalidomide
7
Etoposide
7
Epoetin Alfa
7
Dalteparin
7
romiplostim
6
Darbepoetin alfa
6
Alemtuzumab
6
merphos
5
apixaban
5
Sirolimus
5
Radiotherapy
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Warfarin
×
Classical hematology
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts